United States Competent Cells Market 2018-2023 report delivers a comprehensive research based study of the market along with the market share, forecast data, in-depth analysis, and detailed overview of the Competent Cells industry with respect to United States market. The Competent Cells market report further emphasizes on driver and restraint factors in the United States and regional level. For complete understanding, the market also provides market segmentation and regional market analysis in United States level market.
In 2017, the Competent Cells market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.
In United States market, the top players include
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Takara Bio
- Promega Corporation
- Beijing TransGen Biotech
- GeneScript Corporation
- Yeastern Biotech
- New England Biolabs
- QIAGEN N.V.
- OriGene Technologies
- Lucigen
- Zymo Research
- Bio-Rad Laboratories
- Bioline
- Delphi Genetics
- IBA GmBH
- Cell Applications
- BioDynamics Laboratory
- Scarab Genomics
- GCC Biotech
- SMOBIO Technology
- Edge BioSystems
Split by product types/category, covering
- Chemically Competent Cells
- Electrocompetent Cells
Split by applications/end use industries, covers
- Subcloning & Routine Cloning
- Phage Display Library Construction
- Toxic/Unstable DNA Cloning
- High-Throughput Cloning
- Protein Expression
- Mutagenesis
- Single-Stranded DNA Production
- Bacmid creation
- Cre-lox recombination (PIR1/PIR2)